ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Performance of 2021 Creatinine and Cystatin C Based Equations without Race in Living Kidney Transplant Donors

A. Liaqat, H. Sawaf, L. Cholin, S. Arrigain, A. Wee, J. Schold, J. Augustine, E. Poggio

Cleveland Clinic, Cleveland, OH

Meeting: 2022 American Transplant Congress

Abstract number: 490

Keywords: African-American, Kidney transplantation, Living donor, Screening

Topic: Clinical Science » Kidney » 42 - Kidney Living Donor: Selection

Session Information

Session Name: Kidney Living Donor & Paired Exchange

Session Type: Rapid Fire Oral Abstract

Date: Tuesday, June 7, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:30pm-5:40pm

Location: Hynes Room 302

*Purpose: New 2021 Creatinine (Cr) and Cystatin C (CysC) based GFR equations without the race factor have been refitted to perform better than either 2009 Cr CKD-EPI (’09 Cr CKD-EPI) or ’12 CysC-Cr CKD-EPI (‘12 CysC-Cr CKD-EPI) equations which use the race factor. The performance of these new GFR estimation equations when compared to previous race-based equations in living kidney donors is yet to be determined.

*Methods: We studied the performance of ’09 Cr CKD-EPI, ’12 CysC-Cr CKD-EPI, ’21 CKD-EPI without race (’21 Cr CKD-EPI), 2021 CysC-Cr CKD-EPI without race (’21 CysC-Cr CKD EPI) equations against measured GFR by cold iothalamate clearance (iGFR) in 287 living kidney donors from 2015 to 2021. We calculated the bias (difference between eGFR and iGFR) and accuracy (percent within 30% of iGFR, P30%) for each of these equations.

*Results: The median (IQR) age of the population was 45 yo (36-54), 38.3% were male and 90.2% were non-blacks (AA). The median (IQR) serum Cr was 0.84 [0.73,0.95] mg/dl and the serum CysC was 0.80 [0.70,0.92] mg/dl. The median (IQR) for iGFR, ’09 Cr CKD-EPI, ’12 CysC-Cr CKD-EPI, ’21 Cr CKD-EPI and ’21 CysC-Cr CKD-EPI were 101 (88-115), 94 (83-105), 100 (90-111), 98 (87-107) and 103 (94-113) ml/min/1.73m2 respectively. Overall performance as measured by bias and accuracy was better for the ’21 CysC-Cr CKD-EPI equation (Bias 0.77 ml/min/1.73m2, P30% 93.7%) when compared to ’09 Cr CKD-EPI (Bias -0.74 ml/min/1.73m2, P30% 93.4%), ’12 CysC-Cr CKD-EPI (Bias -2.8 ml/min/1.73m2, P30% 94.1%) and ’21 Cr CKD-EPI (Bias -4.6 ml/min/1.73m2, P30% 94.4%). However performance is very variable across different age groups, gender and race. For non-AA donors, smallest bias was observed with the ’21 CysC Cr-CKD EPI while the other three equations underestimated the GFR. Accuracy was highest for AA using both the new 2021 equations (P30% 94%) but using ’21 Cr CKD-EPI led to underestimation of the GFR (Bias -7.4).

*Conclusions: The new 2021 CysC-Cr CKD-EPI equation performs better in regards to bias and accuracy for all living kidney donors. In AA living donors, both bias and accuracy was superior using the 2021 CysC-Cr based CKD-EPI equation. In conclusion, implementation of 2021 CysC-Cr CKD EPI would lead to better estimates of GFR for potential living kidney donor candidates.

Bias and Accuracy, Statistics as Median (P25, P75) and percent within 30% of iGFR (P30%)
Subset Overall N= 287 ’09 Cr CKD-EPI – Bias / P30% ‘12 CysC-Cr CKD-EPI – Bias / P30% ’21 Cr CKD-EPI – Bias / P30% ’21 CysC-Cr CKD-EPI – Bias / P30%
Age 18-35 74 -0.73 [-11.5, 7.8] / 90.5 4.3 [-7.5, 12.8] / 93.2 0.98 [-10.0, 10.6] / 91.9 6.5 [-4.6, 13.8] / 93.2
Age 36-45 78 -8.0 [-17.2, 3.1] / 97.4 -6.4 [-13.2, 11.0] / 94.9 -5.0 [-16.0, 4.9] / 94.9 -3.6 [-11.1, 13.7] / 94.9
Age > 46 135 -10.8 [-19.8, 0.02] / 92.6 -4.6 [-12.5, 7.7] / 94.1 -7.1 [-16.7, 2.7] / 95.6 0.34 [-9.1, 11.1] / 93.3
Non-AA 270 -7.8 [-17.8, 3.5] / 93.7 -3.6 [-12.4, 9.5] / 94.8 -4.3 [-14.1, 7.0] / 94.4 0.23 [-9.0, 12.3] / 93.7
AA 17 2.2 [-1.9, 10.8] / 88.2 15.1 [6.5, 25.7] / 82.4 -7.4 [-13.2, -2.1] / 94.1 6.6 [1.6, 20.2] / 94.1
Male 110 -6.7 [-16.0, 5.0] / 92.7 1.8 [-9.8, 12.0] / 93.6 -3.2 [-12.5, 7.5] / 94.5 5.0 [-6.9, 15.5] / 91.8
Female 177 -7.7 [-19.2, 3.7] / 93.8 -4.6 [-12.5, 9.5] / 94.4 -5.4 [-16.0, 5.4] / 94.4 -2.2 [-10.0, 10.2] / 94.9
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Liaqat A, Sawaf H, Cholin L, Arrigain S, Wee A, Schold J, Augustine J, Poggio E. Performance of 2021 Creatinine and Cystatin C Based Equations without Race in Living Kidney Transplant Donors [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/performance-of-2021-creatinine-and-cystatin-c-based-equations-without-race-in-living-kidney-transplant-donors/. Accessed May 18, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences